Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

SELL
$78.22 - $90.4 $576,872 - $666,700
-7,375 Reduced 42.13%
10,130 $793,000
Q2 2023

Aug 03, 2023

BUY
$79.47 - $91.38 $61,827 - $71,093
778 Added 4.65%
17,505 $1.54 Million
Q1 2023

May 08, 2023

BUY
$76.72 - $87.58 $1.28 Million - $1.46 Million
16,727 New
16,727 $1.35 Million
Q3 2022

Nov 04, 2022

BUY
$80.75 - $95.31 $117,249 - $138,390
1,452 Added 13.53%
12,180 $992,000
Q2 2022

Aug 11, 2022

BUY
$87.4 - $113.09 $145,958 - $188,860
1,670 Added 18.44%
10,728 $970,000
Q1 2022

May 09, 2022

BUY
$100.58 - $112.38 $360,277 - $402,545
3,582 Added 65.41%
9,058 $1.01 Million
Q4 2021

Feb 10, 2022

SELL
$99.53 - $127.75 $3,682 - $4,726
-37 Reduced 0.67%
5,476 $566,000
Q3 2021

Nov 12, 2021

SELL
$122.75 - $135.17 $59,533 - $65,557
-485 Reduced 8.09%
5,513 $691,000
Q2 2021

Aug 06, 2021

BUY
$118.19 - $131.5 $65,359 - $72,719
553 Added 10.16%
5,998 $745,000
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $44,249 - $47,656
-398 Reduced 6.81%
5,445 $643,000
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $68,085 - $79,303
677 Added 13.1%
5,843 $685,000
Q3 2020

Oct 30, 2020

BUY
$90.13 - $108.78 $222,440 - $268,469
2,468 Added 91.48%
5,166 $537,000
Q2 2020

Aug 13, 2020

SELL
$84.11 - $103.33 $102,445 - $125,855
-1,218 Reduced 31.1%
2,698 $247,000
Q1 2020

May 12, 2020

SELL
$72.92 - $121.3 $95,014 - $158,053
-1,303 Reduced 24.97%
3,916 $353,000
Q4 2019

Feb 13, 2020

BUY
$104.49 - $114.54 $174,707 - $191,510
1,672 Added 47.14%
5,219 $592,000
Q3 2019

Nov 13, 2019

BUY
$98.02 - $111.18 $102,332 - $116,071
1,044 Added 41.71%
3,547 $385,000
Q2 2019

Aug 12, 2019

BUY
$84.15 - $99.38 $210,627 - $248,748
2,503 New
2,503 $244,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $115B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Wealth Shield Partners, LLC Portfolio

Follow Wealth Shield Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.